Connect with us
[bsa_pro_ad_space id=12]

COVID-19

Leading cause of death in Alberta (BY A LONG SHOT) is “Unknown”. Why isn’t our next Premier talking about this?

Published

8 minute read

If you were to ask 10 random Albertans what the leading cause of death was in 2021, many would respond with either COVID-19, or perhaps cancer.  If they really pay attention to things like this they might say heart disease or maybe dementia (old age).

Lucky for us the Province of Alberta has made the cause of death statistics public since 2001.  If you’d like to see them, click here and download “Leading Causes of Death”. If you do, you’ll see that for 15 years in a row, from 2001 to 2015 the leading cause of death for Albertans was heart disease. Dementia makes a strong push toward the end of that time frame.  By 2016 dementia became the leading cause of death for the next 5 years in a row.  Here’s what the list of the top 10 causes of death looked like in 2019. That was the last year ‘before’ COVID-19 appeared on the list.

2019 Organic dementia 1 1997
2019 All other forms of chronic ischemic heart disease 2 1886
2019 Malignant neoplasms of trachea, bronchus and lung 3 1523
2019 Other chronic obstructive pulmonary disease 4 1159
2019 Acute myocardial infarction 5 1061
2019 Atherosclerotic cardiovascular disease, so described 6 678
2019 Accidental poisoning by and exposure to drugs and other biological substances 7 677
2019 Stroke, not specified as hemorrhage or infarction 8 602
2019 Diabetes mellitus 9 569
2019 Other ill-defined and unknown causes of mortality 10 522

Then along came COVID-19.  In 2020 dementia remained the leading cause of death for Albertans, but COVID-19 came charging out of nowhere to become the 6th most common cause of death.  It’s important to note though the stats say COVID-19 “identified”.  That makes it unclear whether COVID was THE cause, A cause, or A symptom.  The other interesting thing to note was that in 2020, suddenly “Unknown Causes” skyrocketed up to the fourth leading cause of death, outpacing even COVID.

2020 Organic dementia 1 2081
2020 All other forms of chronic ischemic heart disease 2 1897
2020 Malignant neoplasms of trachea, bronchus and lung 3 1563
2020 Other ill-defined and unknown causes of mortality 4 1464
2020 Other chronic obstructive pulmonary disease 5 1178
2020 COVID-19, virus identified 6 1084
2020 Acute myocardial infarction 7 1067
2020 Accidental poisoning by and exposure to drugs and other biological substances 8 920
2020 Diabetes mellitus 9 743
2020 Atherosclerotic cardiovascular disease, so described 10 670

In 2021 you might expect COVID-19 would leap into top place in the list of leading causes of death for Albertans. That’s not what happened.  COVID did climb from the 6th most common cause of death to the 3rd most common cause, but at the same time “Unknown causes of mortality” EXPLODED into the top position.

Looking back on the last 20 years before 2021 the number 1 cause of death ranged from a low of 1,581 people dying of heart disease in 2012, to a high of 2,018 people dying of dementia in 2020.  It was only 2020 when the number of people dying from any single cause topped 2,000 for the first time.

Then in 2021 a whopping 2,135 people died of dementia.  That would be enough to be the number one cause of death any other year since records have been kept. Except it wasn’t because in 2021 3,362 people died of unknown causes! Not only did “unknown causes” of death rise above that threshold of 2,100.  It DEMOLISHED that number.

2021 Other ill-defined and unknown causes of mortality 1 3362
2021 Organic dementia 2 2135
2021 COVID-19, virus identified 3 1950
2021 All other forms of chronic ischemic heart disease 4 1939
2021 Malignant neoplasms of trachea, bronchus and lung 5 1552
2021 Acute myocardial infarction 6 1075
2021 Other chronic obstructive pulmonary disease 7 1028
2021 Diabetes mellitus 8 728
2021 Stroke, not specified as hemorrhage or infarction 9 612
2021 Accidental poisoning by and exposure to drugs and other biological substances 10 604

It’s worth repeating, in 2021 “Unknown Causes” were responsible for the deaths of 3,362 Albertans! That’s over 50% more deaths than any of the leading causes since records have been made public!

Considering the Government of Alberta closed businesses, schools, and recreation centres for a virus responsible for 1,950 deaths in 2021 it is astounding that our media isn’t screaming and our government is not aggressively trying to figure out what caused the deaths of 3,362 Albertans!

It’s not just Alberta and Canada seeing this alarming trend.  In England officials are reporting an increase in excess deaths of over 15% compared to the 5 year average. ” Harley Street GP Charles Levinson told The Spectator that while “every slight bump or uptick in the Covid numbers demands endless column inches”, there had been “total silence from so many” on the “damning” overall death statistics. “

British health researcher John Campbell reveals the situation in England.

It used to be the media’s job to take the data and ask questions.  Somehow they’ve failed to recognize the significance of THE LEADING CAUSE OF DEATH sweeping much of the planet.

If you were unable to come up with your own questions when you watched John Campbell’s video, you might very much appreciate this commentary from Jimmy Dore.

After 15 years as a TV reporter with Global and CBC and as news director of RDTV in Red Deer, Duane set out on his own 2008 as a visual storyteller. During this period, he became fascinated with a burgeoning online world and how it could better serve local communities. This fascination led to Todayville, launched in 2016.

Follow Author

Brownstone Institute

FOIA Doc Shows BioNTech Founders Postdated Start of C19 Vax Project

Published on

From the Brownstone Institute

BY Robert KogonROBERT KOGON

As noted in my last article on BioNTech’s “brazen” avoidance of safety testing of its Covid-19 vaccine, BioNTech founders Ugur Sahin and Özlem Türeci claim in their book The Vaccine that the company’s Covid-19 vaccine project got underway on January 27, 2020. But documentary evidence released in response to a FOIA request (and included in the so-called “Pfizer documents”) shows that this is not true and that the company had in fact already begun preclinical, i.e. animal, testing nearly two weeks earlier, on January 14.

BioNTech R&D STUDY REPORT No. R-20-0072 is available here. The report is also referenced and discussed in an FDA submission on the preclinical study program that is available here. The below screenshot shows the study dates from p. 8 of the report.

In the book, Sahin claims furthermore that he only even became interested in the outbreak in Wuhan on January 24, after reading an article in the German weekly Der Spiegel (p. 4) and/or a submission to The Lancet (p. 6). But look again at the study dates above. BioNTech had already completed the first preclinical study for its Covid-19 vaccine the day before!

January 24, 2020 was a Friday. On Sahin’s account, he took the decision to launch his Covid-19 vaccine project over the weekend and unveiled his plans to his collaborators at BioNTech’s headquarters in Mainz, Germany on the following Monday: January 27 (ch. 2 passim and p. 42; see screencap below).

Sahin claims (p. 33) that it was at this January 27 meeting that he asked BioNTech’s animal testing team to prepare the preclinical program that was in fact already underway!

It should be noted that January 14, 2020, the start-date of the first preclinical study, was just two weeks after the first report of Covid-19 cases in Wuhan and just a day after the release of the full SARS-CoV-2 genome (drafts had been released previously).

BioNTech’s first preclinical study was evidently prepared before publication of the genome and in anticipation of it. As explained in the summary of the study (p. 6), its purpose was to test BioNTech mRNA formulated in lipid nanoparticles produced by the Canadian firm Acuitas. But the mRNA was here encoding a proxy antigen (luciferase), not the spike protein of SARS-CoV-2 that would later serve as the target antigen.

The study looked at both biodistribution and immune system activation. As the FDA submission on the preclinical program puts it, “Platform properties that support BNT162b2 were initially demonstrated with non-SARS-CoV-2 antigens” (2.4 NONCLINICAL OVERVIEW, p. 7).

In The Vaccine, which was written with the journalist Joe Miller, Sahin and Türeci talk about the need to obtain the Acuitas lipids, which, they say, were more suitable for intramuscular injection than BioNTech’s own in-house lipids. But, again, they postdate the matter. Thus, on p. 52, we read: “The missing piece was still Acuitas, who had not yet consented to the use of their lipids. Then, on the morning of Monday 3 February, [Acuitas CEO] Tom Madden offered his help.” But BioNTech was already running tests using the Acuitas lipids three weeks earlier!

Furthermore, BioNTech was not able to formulate its mRNA into the lipids itself, but depended on the Austrian company Polymun to do this for it. As noted in The Vaccine (p.51), Polymun’s facilities are an 8-hour drive from BioNTech’s headquarters in Mainz. In the book, Sahin and Türeci describe the first batch of mRNA for the vaccine tests proper being packed up and driven by car to Polymun outside Vienna: “A couple of days later, a small Styrofoam box containing frozen vials full of vaccine would be driven back over the border to BioNTech” (pp. 116-117).

But presumably this same back-and-forth had to have occurred with the mRNA encoding the luciferase. This means that as a practical matter “Project Lightspeed” must have gotten underway even earlier: at least several days before the January 14 start date of the study.

Why did Sahin and Türeci postdate the launch of their Covid-19 vaccine project in their book? Well, undoubtedly because the actual start date – and we do not know when exactly the actual start date was – would have seemed far too soon. Based on the above considerations, it must have been at the latest just days after the first December 31, 2019 report of Covid-19 cases in Wuhan.

Author

  • Robert Kogon

    Robert Kogon is a pen name for a widely-published financial journalist, a translator, and researcher working in Europe. Follow him at Twitter here. He writes at edv1694.substack.com.

Continue Reading

Alberta

Preston Manning picked to chair review of Alberta’s COVID response

Published on

Premier Danielle Smith has struck a committee to investigate how the Alberta government responded to the COVID-19 pandemic and has appointed former Reform Party leader Preston Manning to chair it.

Smith, in a statement, says Manning and the panel will take feedback virtually from experts and the public, then issue a final report and recommendations by Nov. 15.

Manning is to pick the other panel members subject to approval by Smith.

The budget is $2 million, and Manning is to be paid $253,000.

Manning and Smith have been critical of government-imposed health restrictions such as masking, gathering rules and vaccine mandates during the pandemic.

Smith has questioned the efficacy of the methods and their long-term effects on household incomes, the economy and mental health.

She has criticized both Dr. Deena Hinshaw, the former chief medical officer of health, and the Alberta Health Services board for failing to provide good advice and help prepare for the pandemic, which she says forced the government to impose health restrictions and vaccine mandates.

Smith replaced Hinshaw and the board shortly after taking office in October.

The premier said Alberta needs to be ready for future health emergencies.

“There are valuable lessons we learned from the Alberta government’s response to the COVID-19 public health emergency,” Smith said in the statement Thursday.

“It’s important that we apply those lessons to strengthen our management of future public health crises, and the panel’s recommendations will be key in doing so.”

This report by The Canadian Press was first published Jan. 19, 2022.

Continue Reading

Trending

X